期刊文献+

TSHR蛋白表达质粒的构建和TSHR蛋白的表达 被引量:2

Plasmid construction and protein expression of TSHR protein
下载PDF
导出
摘要 目的 :为获得足量的TSHR蛋白及建立Graves’病的动物模型。方法 :将构建于pCRTM3中的TSHRcDNA经限制性内切酶处理后 ,重新构建于表达型载体PinPointX质粒中 ,经酶切分析和PCR检测 ,并在E coliJM10 9中表达 ,Westernblotting免疫印迹法检测其免疫活性。结果 :证明TSHRcDNA基因正确地重组于PinPointX中 ,并在E coliJM10 9中表达 ,12 %SDS聚丙烯酰胺凝胶电泳测定表达产物TSHR蛋白分子量为 10 7kD ,Westernblotting免疫印迹法证实其具有免疫活性。结论 :已成功地重组了TSHR的表达质粒 ,并得到了有相应免疫活性的TSHR蛋白。 Objective:To acquire sufficient TSHR protein,and establish animal models of Graves'disease Methods:TSHR cDNA which had been constructed in plasmid pCR TM 3 was digested with the restriction enzymes , TSHR cDNA then reconstructed in expression vector PinPoint X The recombinant plasmid DNA was amplified with PCR or digested with BamHⅠ、BglⅡ,then TSHR protein immunoreactivity was detected with Western blotting Results:Only the recombinant plasmid TSHR/PinPoint X 3 that contained TSHR cDNA fragment was discovered,and it was expressed in the cells of E coli JM109 The molecular weight of the recombinant fusion protein was about 107 kD in 12% SDS-PAGE By using Western blotting, it was confirmed that TSHR protein has immunoreactivity Conclusion:The recombinant expression plasmid of TSHR has been successfully constructed, the corresponding immunoreactivity TSHR protein has been acquired
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2000年第10期529-532,共4页 Chinese Journal of Immunology
基金 卫生部临床重点课题项目!基金 (0 5 5 )资助
关键词 TSH受体 Graves'病 免疫印迹法 质粒 TSH receptor Graves’disease Western blotting
  • 相关文献

参考文献3

  • 1Wilson K P,Pin Point TM Xaprote inpurification system technical mannual,1996年,7页
  • 2金冬雁(译),分子克隆实验指南(第2版),1995年,16-69,237-244,259-26页
  • 3Kosugi S,Mol Endocrinol,1993年,7卷,114页

同被引文献11

  • 1詹升华,张徽,刘纯.pcDNA3.1/hTSHR真核表达载体的构建及其在COS-7细胞中的表达[J].细胞与分子免疫学杂志,2004,20(4):390-393. 被引量:6
  • 2吴晓燕,雒文田,徐利,田竹芳,王琛,施秉银,朱本章.人TSH受体胞外段高效表达质粒的构建、表达及蛋白纯化[J].中华内分泌代谢杂志,2004,20(5):470-471. 被引量:4
  • 3武敏,施秉银,伍丽萍,兰玲,吴小燕,张进安,徐莉.人TSHR膜外区cDNA克隆及真核表达载体的构建[J].西安交通大学学报(医学版),2007,28(2):123-125. 被引量:2
  • 4CHEN CR,MCLACHLAN SM,RAPOPORT B.Identification of key amino acid residues in a thyrotropin receptor monoclonal antibody epitope provides insight into it's inverse agonist and antagonist properties[J].Endocrinology,2008,149(7):3427-3434.
  • 5CHAZENBALK GD,PICHURIN P,CHEN CR,et al.Thyroid stimulating autoantibodies in Graves disease preferentially recognize the free A subunit,not the thyrotropin holoreceptor[J].J Clin Invest,2002,110(2):209-217.
  • 6NAGAYAMA Y.Graves' animal models of Graves' hyperthyroidism[J].Thyroid,2007,17(10):981-988.
  • 7SCHOTT M,ECKSTEIN A,WILLENBERG HS,et al.Improved prediction of relapse of Graves' thyrotoxicosis by combined determination of TSH receptor and thyroperoxidase antibodies[J].Horm Metab Res,2007,39(1):56-61.
  • 8KOPP P.The TSH receptor and its role in thyroid disease[J].Cell Mol Life Sci,2001(58):1301-1322.
  • 9RAPOPORT B,MCLACHLAN SM,KAKINUMA A,et al.Critical relationship between autoantibody recognition and thyrotropin receptor maturation as reflected in the acquisition of complex carbohydrate[J].J Clin Endocrinol Metab,1996,81(7):2525-2533.
  • 10雒文田,王琛,徐莉,马秀萍.用表达重组TSH受体的CHO细胞测定Graves'甲亢病人血清中的TSAb[J].西安医科大学学报,1999,20(2):217-218. 被引量:1

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部